Thanks to expert staff, Wockhardt has become a leading global Pharmaceutical Contract Manufacturer.
Lyophilisation I Sterile injectables I Solid Dose I Liquids I Ointments I Creams I Powders I Specialised products
Meet the Wockhardt team …
… Performance delivery is what really counts.
Thanks to expert staff, Wockhardt has become a leading global Pharmaceutical Contract Manufacturer. From development to high-volume commercial manufacture, we utilise more than 25 years of contract manufacturing experience to ensure your product is professionally managed all the way to market.
We offer a “Full Turnkey” value-added service from API production and product development through to scale-up with global options to maintain a competitive advantage. With a network of 12 facilities located throughout the US, Europe and Asia we aim to provide our cost-effective services where and when you need them. From biotechnology to leading global pharmaceutical companies, Wockhardt is ideally placed to meet your needs.
Our flexible, end-to-end service is redefining manufacture for a range of sterile injectables and other dosage forms. We’re also significantly expanding our lyophilisation capabilities to meet global regulatory requirements by investing in new sterile facilities.
Wockhardt gets results fast. From initial agreement to production, our average time to completion of technology transfer is just 4 months. We’ve even completed some programmes within just 2.
Our staff are experts in their own fields and they are dedicated to providing you with extraordinary service every day. Just think, what could the Wockhardt team achieve for you?
Wockhardt – Delivering Extraordinary Service Everyday
Contact details:
Mark Bridgewater, Head of Contract Manufacturing Services
Tel: +44 (0)1978 661261
E-mail: knowhow@wockhardt.com
Web address: www.wockhardt-knowhow.com
Visit us at: ICSE / Cphi Worldwide, 5-7 October 2010, Paris Nord Villepinte,
www.icsexpo.com
,
www.cphi.com
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
PacBio Chosen as Tech Partner for Global Alzheimer’s Disease Research Project
April 23rd 2025The project, the North African Dementia Registry, will unite multiple entities for the purpose of developing a comprehensive dataset to advance the research community’s understanding of Alzheimer’s disease and other dementias in diverse populations.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.